Source:http://linkedlifedata.com/resource/pubmed/id/19235854
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-3-2
|
pubmed:abstractText |
Infection with hepatitis C virus (HCV) is associated with lymphoproliferative disorders, represented by essential mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma, but the pathogenic mechanism remains obscure. HCV may infect B cells or interact with their cell surface receptors, and induce lymphoproliferation. The influence of HCV infection of B cells on the development of lymphoproliferative disorders was evaluated in 75 patients with persistent HCV infection. HCV infection was more prevalent (63% vs. 16%, 14%, or 17% P < 0.05 for each), and HCV RNA levels were higher (3.35 +/- 3.85 vs. 1.75 +/- 2.52, 2.15 +/- 2.94 or 2.10 +/- 2.90 log copies/100 ng, P < 0.01 for each) in B cells than CD4(+), CD8(+) T cells or other cells. Negative-strand HCV RNA, as a marker of viral replication, was detected in B cells from four of the 75 (5%) patients. Markers for lymphoproliferative disorders were more frequent in the 50 patients with chronic hepatitis C than the 32 with chronic hepatitis B, including cryoglobulinemia (26% vs. 0%, P < 0.001), low CH(50) levels (48% vs. 3%, P = 0.012), and the clonality of B cells (12% vs. 0%, P < 0.01). By multivariate analysis, HCV RNA in B cells was an independent factor associated with the presence of at least one marker for lymphoproliferation (odds ratio: 1.98 [95% confidence interval: 1.36-7.24], P = 0.027). Based on the results obtained, the infection of B cells with HCV would play an important role in the development of lymphoproliferative disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1096-9071
|
pubmed:author |
pubmed-author:HiroishiKazumasaK,
pubmed-author:ImawariMichioM,
pubmed-author:InokuchiMomokoM,
pubmed-author:ItoTakayoshiT,
pubmed-author:MiyakawaYuzoY,
pubmed-author:MorikawaKenichiK,
pubmed-author:NozawaHisakoH,
pubmed-author:ShimazakiTomoeT,
pubmed-author:ShimozumaYuuY,
pubmed-author:UchikoshiManabuM
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-27
|
pubmed:meshHeading |
pubmed-meshheading:19235854-Adult,
pubmed-meshheading:19235854-Aged,
pubmed-meshheading:19235854-Amino Acid Sequence,
pubmed-meshheading:19235854-B-Lymphocytes,
pubmed-meshheading:19235854-Female,
pubmed-meshheading:19235854-Genes, Immunoglobulin Heavy Chain,
pubmed-meshheading:19235854-Hepacivirus,
pubmed-meshheading:19235854-Hepatitis C, Chronic,
pubmed-meshheading:19235854-Humans,
pubmed-meshheading:19235854-Lymphoproliferative Disorders,
pubmed-meshheading:19235854-Male,
pubmed-meshheading:19235854-Middle Aged,
pubmed-meshheading:19235854-Molecular Sequence Data,
pubmed-meshheading:19235854-Prevalence,
pubmed-meshheading:19235854-RNA, Viral,
pubmed-meshheading:19235854-Virus Replication
|
pubmed:year |
2009
|
pubmed:articleTitle |
Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
|
pubmed:affiliation |
Department of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|